Back to BANK OF AMERICA CORP /DE/ BANK OF AMERICA CORP /DE/

EPRXEPRX
6 quarters

Position history for BANK OF AMERICA CORP /DE/BANK OF AMERICA CORP /DE/'s holdings in EUPRAXIA PHARMACEUTICALS INC

BANK OF AMERICA CORP /DE/ holds 264,721 shares of EPRX (EUPRAXIA PHARMACEUTICALS INC), worth $1.7M as of 2026-Q2. The position was decreased (-1.3% shares). EPRX represents 0.0% of BANK OF AMERICA CORP /DE/'s portfolio.

Current Value

$1.7M

Current Shares

264,721

Total Value Change

+$1.7M

Total Shares Change

+262,221

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
264,721
-1.3%
$1.7M0.0%$6.61
0
2026-Q1
Increased
268,221
+5.9%
$1.9M0.0%$8.02
27
2025-Q4
Increased
253,321
+455.8%
$1.9M0.0%$7.59
42
2025-Q3
Increased
45,577
+262.9%
$268,9040.0%$5.75
26
2025-Q2
Increased
12,559
+402.4%
$72,3400.0%$5.30
23
2025-Q1
New
2,500
-
$8,2000.0%$3.38
25

Other major holders of EPRX: BALYASNY ASSET MANAGEMENT L.P., SCOTIA CAPITAL INC.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used